Aller au contenu principal
Profil bibliographique

María Celeste

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

65Publications signalées
156Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Antibiotic Resistance in BacteriaNosocomial Infections in ICUAntibiotic Use and ResistanceRegional Development and InnovationPsychological Treatments and Disorders

Les publications récentes

Accès ouvert 2025 article OpenAlex

Ceftolozane/tazobactam use and emergence of resistance: a 4-year analysis of antimicrobial susceptibility in Pseudomonas aeruginosa isolates in a tertiary hospital

Alessandra Imeneo, Laura Campogiani, Pietro Vitale, Andrea Di Lorenzo et autres

Background Ceftolozane/tazobactam (C/T) was temporarily withdrawn from December 2020 to February 2022: this forced unavailability created the conditions to study how drug discontinuation might influence Pseudomonas aeruginosa (PA) resistance reversibility in a real-life setting. Methods Clinically relevant PA isolates collected between January …

it (code pays fourni par la source)

4 citations Frontiers in Microbiology
Accès ouvert 2025 article OpenAlex

Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy

Federico Pirrò, Giacomo Caldarola, Nicoletta Bernardini, María Celeste et autres

INTRODUCTION: Risankizumab and secukinumab are effective treatment options for patients with moderate to severe psoriasis. OBJECTIVES: We sought to estimate the efficacy and the cost per responder of risankizumab and secukinumab by comparing these two drugs in a real-life setting. METHODS: A …

it (code pays fourni par la source)

1 citation Dermatology Practical & Conceptual
2024 article OpenAlex

Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series

Giovanni Di Mauro, Giovanni Vietri, L Quaranta, Fabio Placidi et autres

INTRODUCTION: Refractory and super-refractory status epilepticus are medical emergencies that must be promptly treated in consideration of their high mortality and morbidity rate. Nevertheless, the available evidence of effective treatment for these conditions is scarce. Among novel antiseizure medications (ASMs), highly purified …

it (code pays fourni par la source)

2 citations CNS & Neurological Disorders - Drug Targets
Accès ouvert 2023 article OpenAlex

Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections

Laura Campogiani, Angela Maria Antonia Crea, Maria Letizia Minardi, L Ansaldo et autres

Background: infections. Methods: This was a retrospective monocentric study including patients hospitalized (>24 hours) at Policlinico Tor Vergata, Rome, Italy, between May 1, 2021, and September 1, 2022, treated with cefiderocol (>48 hours). The primary objective was early clinical improvement at 48-72 …

it (code pays fourni par la source)

7 citations Open Forum Infectious Diseases
Accès ouvert 2023 article OpenAlex

Highly purified cannabidiol improves stability and postural tone in adult patients with Lennox–Gastaut syndrome: A case series

Carmen Calvello, Mariana Fernandes, Clementina Lupo, Fabio Placidi et autres

Lennox-Gastaut syndrome (LGS) is a severe developmental epileptic encephalopathy associated with numerous neurological signs and symptoms. Altered postural tone and the need for a caregiver-assisted wheelchair are features characterizing patients with LGS. Highly purified cannabidiol (CBD) is a novel antiseizure medication (ASM) …

it (code pays fourni par la source)

1 citation Epileptic Disorders
2021 article OpenAlex

Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life

Fiorenzo Santoleri, Elena Ranucci, Gaetano La Barba, Irene Colasanto et autres

BACKGROUND: The use of dasatinib and nilotinib in the treatment of patients with chronic myeloid leukemia represents a valid therapeutic option for patients resistant or intolerant to imatinib. In this multicentre study, adherence, persistence and efficacy in real life over two years …

it (code pays fourni par la source)

7 citations Current Medical Research and Opinion
2019 dissertation OpenAlex

Centro de Idiomas UCSG.

Subía Franco, María Celeste

El presente trabajo de titulacion muestra del desarrollo del proyecto arquitectonico Centro de Idiomas para la Universidad Catolica de Santiago de Guayaquil ubicado en la parroquia La Puntilla, perteneciente al canton Samborondon. La propuesta responde ante dos principales interrogantes que surgen al …

0 citations
2019 dissertation OpenAlex

Sistematización de la experiencia de la evaluación del espacio y los medios idóneos utilizados para el desarrollo de la campaña “Quítale el Disfraz”, campaña contra el acoso callejero.

Baduy Espinoza, María Celeste

Actualmente, nos encontramos rodeados de diferentes problematicas sociales, una de esas es la violencia de genero. Este tipo de violencia afecta a mas personas de lo que pensamos, muchas estadisticas sorprendentes han sido reveladas los ultimos anos, como por ejemplo, su expresion …

0 citations

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.